I Eckerle, B Meyer - Lancet (London, England), 2020 - europepmc.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has surprised the world with its range of disease manifestations, from asymptomatic infection to critical illness …
I Eckerle, B Meyer - 2020 - cabidigitallibrary.org
Extensive previous assay validation in well characterised serum samples and confirmation of positive results are thus necessary to prevent false-positive findings from confounding …
I Eckerle, B Meyer - Lancet (London, England), 2020 - folia.unifr.ch
SARS-CoV-2 seroprevalence in COVID-19 hotspots. SONAR logo Log in Sign up EN English Français Deutsch Italiano Back Full-text Journal article SARS-CoV-2 …
I Eckerle, B Meyer - Lancet (London, England), 2020 - sonar.ch
SARS-CoV-2 seroprevalence in COVID-19 hotspots. SONAR logo Log in Sign up EN English Français Deutsch Italiano Back Full-text Journal article SARS-CoV-2 …
I Eckerle, B Meyer - The Lancet, 2020 - thelancet.com
SARS-CoV-2 seroprevalence in COVID-19 hotspots - The Lancet Skip to Main Content Advertisement The Lancet Journal This Journal Back Journal Home Online First Current Issue …
I Eckerle, B Meyer - Lancet (London, England), 2020 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has surprised the world with its range of disease manifestations, from asymptomatic infection to critical illness …
I Eckerle, B Meyer - Lancet (London, England), 2020 - europepmc.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has surprised the world with its range of disease manifestations, from asymptomatic infection to critical illness …